Company: Raisio.
MIMS Ireland
-
Benecol
-
Braltus
Company: Teva Pharmaceuticals Ireland.
-
Doublebase
Company: Dermal Laboratories Ltd.
-
Imatinib Rowex
Company: Rowex Ltd.
-
Prapexin
Company: Rowex Ltd.
-
Zepatier ▼
Company: MSD Ireland (Human Health) Ltd.
Abbreviated prescribing information
-
Codipar 15mg/500mg Effervescent Tablets (codeine phosphate + paracetamol)
PRESCRIBING INFORMATION Presentation: Each capsule contains codeine phosphate hemihydrate 15mg and paracetamol 500mg.
About MIMS Ireland
-
Topics for Supplements, Clinical Specials and Fact Files 2016
Note: The schedule is subject to change.
-
Information for Healthcare Professionals
MIMS or Monthly Index of Medical Specialities is an independently edited publication designed as a
-
Information for Pharmaceutical Companies
Policy Product inclusion Drugs can be included in MIMS Ireland if they have a Product
Clinical specials
-
Focus on Type 2 Diabetes – ICGP Guidelines 2016
The ICGP’s ‘Practical Guide to Integrated Type 2 Diabetes Care’, launched in 2016, advocates an
-
Antihyperglycaemic Therapy in Type 2 Diabetes – List of agents available in Ireland
Download PDF Table 1.
-
Options for Hormone Replacement Therapy
Download PDF Updated September 2016 MIMS Ireland Copyright®
Discontinued products
-
Fluanxol Discontinued
Lundbeck Ireland Ltd.
-
Vantas Implant – Termination of Supply
Orion Corporation regrets to inform you that they have ceased supply of Vantas (histrelin) implant
-
Clopixol Acuphase 50mg/ml & Depixol 200mg/ml Injections
Lundbeck (Ireland) Ltd wishes to announce the discontinuation of the following products from the Irish
Drug Interactions
-
Medications to Avoid in Women Taking Tamoxifen
Medications that should be avoided by women who are taking tamoxifen for the prevention of
-
Interactions with Angiotensin II receptor antagonists
Concomitant use not recommended Potassium sparing diuretics or potassium supplements Angiotensin II receptor antagonists attenuate
-
Interaction between insulin and other medicinal products
A number of medicinal products are known to interact with glucose metabolism.
Fact Files
-
Spiolto Respimat
Maintenance bronchodilator treatment to relieve symptoms in adults with COPD Spiolto Respimat is a fixed
-
Binosto
A once weekly, buffered alendronate solution for the treatment of osteoporosis Clonmel Healthcare Ltd is
-
Vesomni
Treatment of storage and voiding symptoms associated with benign prostatic hyperplasia Astellas wish to announce
HPRA - Safety update
-
Otezla (apremilast) – Important advice regarding suicidal ideation and behaviour
Apremilast is a selective immunosuppressant medicine indicated for use alone or in combination with disease
-
Direct-Acting Antivirals for Hepatitis C: Advice on interaction potential with warfarin and other vitamin K antagonists leading to a reduced international normalised ratio (INR)
Direct-Acting Antivirals (Daklinza, Exviera, Harvoni, Olysio, Sovaldi, Victrelis, Viekirax, Zepatier and Epclusa)* are used to
-
Fingolimod (Gilenya) – Risks related to immunosuppressive effects
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) advised that healthcare professionals and patients
Interchangeable Medicines
-
Interchangeable Medicines and Reference Pricing
The Health (Pricing and Supply of Medical Goods) Act 2013 has introduced a system of
Medicines and sport
-
Anti-Doping: 2017 Guide for Prescribers
The World Anti-Doping Code, published by the World Anti-Doping Agency (WADA), harmonises anti-doping regulations across
-
World Anti-Doping Agency announces changes to its Prohibited List for 2017
The World Anti-Doping Agency (WADA) has issued a new Prohibited List of Substances and Methods
-
Hay Fever Policy (Glucocorticoid Injections)
Therapeutic Use Exemption (TUE) Committee Policy on Glucocorticoid Injections for Hay Fever Depo-Medrone (Methylprednisolone) and
New clinical evidence
-
Praxbind ▼ Approved for the Specific Reversal of the Anticoagulant Effects of Pradaxa
Download PDF Boehringer Ingelheim Ltd.
-
Gazyvaro Now Available for Previously Untreated Chronic Lymphocytic Leukaemia
Download PDF Roche is pleased to announce that Gazyvaro (obinutuzumab) is now available in Ireland
-
Xigduo▼ (Dapagliflozin/Metformin) now Authorised in Ireland for Adults with Type 2 Diabetes
Download PDF Forxiga▼ (dapagliflozin) was launched in Ireland in April 2014 and was the
New products
-
Benecol
Company: Raisio.
-
Braltus
Company: Teva Pharmaceuticals Ireland.
-
Doublebase
Company: Dermal Laboratories Ltd.
New this month
-
World Anti-Doping Agency announces changes to its Prohibited List for 2017
The World Anti-Doping Agency (WADA) has issued a new Prohibited List of Substances and Methods
-
Bufomix Easyhaler – New 80/4.5mcg Strength
Orion Pharma Ireland is pleased to announce the addition of Bufomix Easyhaler 80/4.
-
Attitudes and Understanding of Cancer Clinical Trials among People with Cancer the Focus of National Study about to be Launched
Details of a new national study ‘Understanding and Attitudes toward Cancer Clinical Research (CCR) among
Research news
-
Attitudes and Understanding of Cancer Clinical Trials among People with Cancer the Focus of National Study about to be Launched
Details of a new national study ‘Understanding and Attitudes toward Cancer Clinical Research (CCR) among
-
Regular aspirin intake halves risk of hereditary cancer
Scientists including those from Queen’s University have discovered that the number of people developing hereditary
-
International Research including UCC identified BP Genes
Scientists from a large international academic consortium including University College Cork (UCC), have identified genetic